About
Technology
Issues
FAQ
Links
Official Page
NRG-GI005 (COBRA): Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer.
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.